Amosulalol

Amosulalol (INN) is an anti-hypertensive drug. It has much higher affinity for alpha-1 adrenergic receptors than for beta adrenergic receptors.[1]

Amosulalol

Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	none
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name (RS)-5-[1-hydroxy-2-[2-(2-methoxyphenoxy)ethylamino]ethyl]-2-methylbenzenesulfonamide
CAS Number	85320-68-9
PubChem CID	2169
ChemSpider	2084
UNII	C69JI1BAU8
KEGG	D07451
ChEMBL	ChEMBL152231
Chemical and physical data
Formula	C18H24N2O5S
Molar mass	380.46 g·mol^−1
3D model (JSmol)	Interactive image
SMILES CC1=C(C=C(C=C1)C(CNCCOC2=CC=CC=C2OC)O)S(=O)(=O)N
InChI InChI=1S/C18H24N2O5S/c1-13-7-8-14(11-18(13)26(19,22)23)15(21)12-20-9-10-25-17-6-4-3-5-16(17)24-2/h3-8,11,15,20-21H,9-10,12H2,1-2H3,(H2,19,22,23) Key:LVEXHFZHOIWIIP-UHFFFAOYSA-N
(verify)

It is not approved for use in the United States.

References

1. Pharmacology of Antihypertensive Therapeutics. Springer. 1990. pp. 180-183.